Predicting Lung Cancer: Risk-Based LDCT Screening vs Age and Pack-Years
Is lung cancer screening using risk-based low-dose computer tomography a better predictor of lung cancer risk than age or pack/years of smoking?
Is lung cancer screening using risk-based low-dose computer tomography a better predictor of lung cancer risk than age or pack/years of smoking?
The 2-year overall survival rate was 32.5%.
Patients with certain cancers have an increased risk of cancer-specific mortality that persists for 30 to 35 years after diagnosis.
How do outcomes of endobronchial ultrasound-guided transbronchial fine needle aspiration differ in patients aged 65 or older vs those younger than 65?
Researchers explored whether a cohort of veterans had received the 3 consecutive annual lung cancer screenings recommended to reduce lung cancer mortality.
Patients diagnosed with cancer more than one year ago and those not receiving active treatment are not at heightened risk for worse COVID-19.
Segmentectomy prolonged 5-year overall survival in a phase 3 trial.
Adolescent and young adult (AYA) cancer survivors have increased incidence and mortality of subsequent primary cancers (SPCs).
The FDA has granted Priority Review to fam-trastuzumab deruxtecan-nxki to treat adults with previously treated HER2-mutant metastatic NSCLC.
Visually and quantitatively assessed emphysema on computed tomography (CT) is associated with increased risk for lung cancer.